Skip to main content

Enstilar News

LEO Pharma Announces U.S. Approval of Enstilar Foam (calcipotriene/betamethasone dipropionate) for Plaque Psoriasis

Ballerup, Denmark 19 October, 2015: LEO Pharma announced today that the U.S. Food and Drug Administration (FDA) has approved Enstilar (calcipotriene/betamethasone dipropionate 50 micrograms/g / 0,5...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Plaque Psoriasis, Psoriasis

Enstilar patient information at Drugs.com